Rapid Pathogen Screening competitorsClear all

Rapid Pathogen Screening's top competitors include Clementia Pharmaceuticals, ProtoKinetix, Magenta Therapeutics and DBV Technologies.
Rapid Pathogen Screening
Rapid Pathogen Screening
Rapid Pathogen Screening provides rapid point-of-care (POC) for identifying patients with infectious diseases.
Clementia Pharmaceuticals
Clementia Pharmaceuticals
Clementia Pharmaceuticals develops and commercializes therapeutics for people suffering from rare diseases.
ProtoKinetix
ProtoKinetix
ProtoKinetix is a bio-technology company that provides medical researchers with a platform for enhancing cell survival and health, both in vitro and in vivo.
Magenta Therapeutics
Magenta Therapeutics
Magenta’s mission is to revolutionize stem cell transplant as the treatment for immune and blood diseases.
DBV Technologies
DBV Technologies
We are committed to finding a safe, effective and patient-friendly therapy for food and pediatric allergy patients, for whom there are no currently approved treatments.
Founding Date
Founding Date
2004
Founding Date
2012
Founding Date
1999
Founding Date
2016
Founding Date
2002
Type
Type
Private
Type
Subsidiary
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Sarasota, US HQ
Locations
Montréal, CA HQ
Newton, US
Locations
Marietta, US HQ
Locations
Cambridge, US HQ
Locations
Montrouge, FR HQ
Bagneux, FR
New York, US
Summit, US
Employees
Employees
13
Employees
4811% decrease
Employees
N/A
Employees
72
Employees
3114% decrease
Valuation ($)
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
35.4 m
Valuation ($)
345.5 m
Valuation ($)
N/A
Twitter followers
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
154
Twitter followers
2 k
Twitter followers
1.4 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
11
Number of tweets (last 30 days)
8
Number of tweets (last 30 days)
N/A
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
2.5
Average likes per tweet (last 30 days)
10.8
Average likes per tweet (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
90.91%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Alexa Website Rank
Alexa Website Rank
N/A
Alexa Website Rank
N/A
Alexa Website Rank
358808
Alexa Website Rank
429432
Alexa Website Rank
292854
Employee Rating
Employee Rating
N/A
Employee Rating
N/A
Employee Rating
N/A
Employee Rating
N/A
Employee Rating
3.2

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
€13.1m (FY, 2019)
Net income
Net income
N/A
Net income
($57.5m) (FY, 2016)
Net income
($4.2m) (FY, 2019)
Net income
($76.8m) (FY, 2019)
Net income
(€153.6m) (FY, 2019)

Funding

Total funding raised
Total funding raised
$ 28m
Total funding raised
$ 92.5m
Total funding raised
N/A
Total funding raised
$ 150.5m
Total funding raised
$ 28.2m
For sources of this data, please see the company profile

View company profiles

Clementia Pharmaceuticals
HQ
Montréal, CA

Clementia Pharmaceuticals develops and commercializes therapeutics for people suffering from rare diseases.

View company
ProtoKinetix
HQ
Marietta, US

ProtoKinetix is a bio-technology company that provides medical researchers with a platform for enhancing cell survival and health, both in vitro and in vivo.

View company
Magenta Therapeutics
HQ
Cambridge, US
Employees
72

Magenta’s mission is to revolutionize stem cell transplant as the treatment for immune and blood diseases.

View company
DBV Technologies
HQ
Montrouge, FR
Employees
311↓ 4% decrease

We are committed to finding a safe, effective and patient-friendly therapy for food and pediatric allergy patients, for whom there are no currently approved treatments.

View company